R Caruso, F Alesiani, R Latagliata. Prolonged low doses of oral etoposide may be effective in individual patients with advanced lymphoproliferative disorders refractory to aggressive chemotherapy. haematol [Internet]. 1997Jan.1 [cited 2024Nov.24];82(1):126-7. Available from: https://haematologica.org/article/view/878